| Literature DB >> 33758299 |
Philip L Molyneaux1,2, Adam Platt3, Slavé Petrovski4, Ryan S Dhindsa5, Johan Mattsson6, Abhishek Nag5, Quanli Wang5, Louise V Wain7,8, Richard Allen7, Eleanor M Wigmore5, Kristina Ibanez5, Dimitrios Vitsios5, Sri V V Deevi5, Sebastian Wasilewski5, Maria Karlsson9, Glenda Lassi10, Henric Olsson6, Daniel Muthas6, Susan Monkley6, Alex Mackay6, Lynne Murray9, Simon Young11, Carolina Haefliger5, Toby M Maher12,13, Maria G Belvisi14,15,16, Gisli Jenkins17,18.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal disorder characterised by progressive, destructive lung scarring. Despite substantial progress, the genetic determinants of this disease remain incompletely defined. Using whole genome and whole exome sequencing data from 752 individuals with sporadic IPF and 119,055 UK Biobank controls, we performed a variant-level exome-wide association study (ExWAS) and gene-level collapsing analyses. Our variant-level analysis revealed a novel association between a rare missense variant in SPDL1 and IPF (NM_017785.5:g.169588475 G > A p.Arg20Gln; p = 2.4 × 10-7, odds ratio = 2.87, 95% confidence interval: 2.03-4.07). This signal was independently replicated in the FinnGen cohort, which contains 1028 cases and 196,986 controls (combined p = 2.2 × 10-20), firmly associating this variant as an IPF risk allele. SPDL1 encodes Spindly, a protein involved in mitotic checkpoint signalling during cell division that has not been previously described in fibrosis. To the best of our knowledge, these results highlight a novel mechanism underlying IPF, providing the potential for new therapeutic discoveries in a disease of great unmet need.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33758299 PMCID: PMC7988141 DOI: 10.1038/s42003-021-01910-y
Source DB: PubMed Journal: Commun Biol ISSN: 2399-3642